Skip to Main Content

View Public Comments for Autologous Blood Derived Products for Chronic Non-Healing Wounds

Use the browser below to select the Comment Period for which you would like to view the comments for the selected document. You can use the alphabetical links above the results table to jump to comments submitted by a commenter whose last name starts with that letter. Select the ‘Expand All Comments’ link to view all the full comments, and click the ‘Collapse All Comments’ link to view only the abstract for all comments. Select the ‘More’ link in the Comment to view the full text of the specific comment in a new window.
The first (earliest) set of comments are displayed by default in the Public Comment Results section. To view additional Comment Periods, use the radio button options and select the "Submit" button.
An asterisk (*) indicates a required field.

      Select one period.



[44 Comments]
Page 1 of 2
FirstPrev12NextLast
First character of titleCommenterComment Information
B
Baker, Michael Date: 07/20/2007
Comment:

One or two applications 2-4 weeks apart has been
more efficacous in promoting closure of
refractory pressure, venous and ischemic arterial
DFU's than 12 weeks of Regranex or 4 week of NPWT
in our out-patient wound care clinic. It More opens in new window

B
Beckman, RN JD CCP LCP, Gary Title: Licensed Clinical Perfusionist, Managing Partner
Organization: Memphis Area Perfusion, PLLC
Date: 07/24/2007
Comment:

The application of this technology has been
increasingly utilized in the treatment of acute
surgical and chronic wound healing with excellent
results supported both in the scientific
literature and by direct clinical observation More opens in new window

B
Beriou, Judy Date: 07/20/2007
Comment:

I am a nurse who has been involved with the development and usage of topical growth factor therapies to chronic wounds. I have witnessed phenomenol results with this thereapy including limb saving situations and/or return to a productive More opens in new window

B
Bilbo, Patrick Title: Vice President, Regulatory & Clinical Affairs & Qu
Organization: Organogenesis, Inc.
Date: 07/25/2007
Comment:

July 25, 2007

VIA E-MAIL AND FEDERAL EXPRESS

Beverly A. Lofton, MHA
Lead Analyst
Centers for Medicare & Medicaid Services
7500 Security Blvd.
Woodlawn, MD 21244
Mail Stop: More opens in new window

B
Brandt, Ryan Date: 07/19/2007
Comment:

As an individual who spends most of his time doing research
and evaluating numbers, I would like to share some statiscal
data regarding chronic non-healing wounds, especially in
diabetic ulcer cases. According to PodiatryToday "17 More opens in new window

B
Brandt, Robert Title: President
Organization: Blood Recovery Systems of Florida, Inc.
Date: 06/28/2007
Comment:

As a clinician being invloved in over 20,000
procedures where PRP was utilized, I can attest
to the fact that this is the most effective
modality that I have seen in wound repair. The
most common question I hear from patients More opens in new window

C
Carcioppolo CCP, Victor Title: Chief Perfusionist
Organization: Southwest General Health Center
Date: 07/20/2007
Comment:

I am the chief perfusionist at a Health Center that performs over 600 PRP/PPP annually. Please reconsider reimbursement for the application of PRP/PPP on non healing wounds. In the podiatry/orthopedic arena, the results are most impressive. We More opens in new window

C
Carraway, MD, Robert Organization: Advanced Wound Care Clinic
Date: 07/24/2007
Comment:

I have been treating chronic non-healing wounds
for over 25 years with many products on the market
(hyperbaric oxygen, platelet gel, Apligraf, VAC,
etc.), including Autologous Platelet Gel. I have
applied Autologous Platelet Gel to More opens in new window

C
Coleman, Ann Title: Assistant Vice President for Nursing Servies
Organization: National Health Care Corporation
Date: 07/13/2007
Comment:

As a nurse practicing in Long Term Care, I
support a national coverage determination that
would include atologous blood derived products
for wound healing.
Having observed the healing capabilities of this
process and product More opens in new window

D
dedo, Douglas Title: President
Organization: Palm Beach Institute of Cosmetic Surgery
Date: 07/03/2007
Comment:

Dear Sir. I was the first surgeon in Florida to
begin using PRP in my
facelifts. From the decreased morbidity with
almost no bruising,
swelling and less pain I began using it on my
endoscopic sinus cases. There
is no More opens in new window

d
Driver, Vickie Title: Chief
Organization: National Center for Limb Preservation
Date: 07/25/2007
Comment:

I find the data encouraging, especially since 2003 for the utilization of platelet rich plasma gel in the treatment of both acute and chronic wounds. My experience with PRP includes participation in the RCT for diabetic foot ulcers and a More opens in new window

F
Fox, Jeffery B Title: Chief Physician Assistiant
Organization: Midwest heart Surgery Inst.
Date: 07/19/2007
Comment:

As we continue to operate on higher acuity diabetics and obese
patients, the sternal healing problems associated with these co
morbidities continue to trend upwards. What does this mean? A
direct increase in rehospitalizations for More opens in new window

F
Frykberg, Robert Title: Chief, Podiatry
Date: 07/23/2007
Comment:

I have used autologous platelet rich plasma gel
to manage chronic diabetic foot ulcers and
consider this technology to be of sufficient
importance in this discipline to be granted
coverage under CMS guidelines. The body of More opens in new window

F
Fulghum, Patsy Title: Wound Ostomy Continence Nurse
Organization: SC DHEC Home Health
Date: 07/17/2007
Comment:

It seems to me the coverage of a product that
will help decrease healing time will save money
in the long run. Of course it should not be used
forever so guidelines need to be followed for
appropriate length of use. Thank More opens in new window

G
Greco, PhD, PA/C, Joseph Date: 06/30/2007
Comment:

I am a board certified Physicians Assistant and have worked as a surgical PA, first assisting, in Orthopedic, General/Vascular surgery for 10 years and hair restoration surgery 25 years. For the past 10 years I have experience working with PRP More opens in new window

G
Gurvich, Leon Title: Case manager, Certified Wound Specialist
Organization: L.Weiss Mem. hospital, Wound Healing Center
Date: 07/10/2007
Comment:

I would like to presesnt a work about the Role of Autologous Blood-Derived Growth Factors in the Treatment of Limb-Threatening Wounds. This work was presesnted in the National Wound Care Conference in San Diego, CA. Leon Gervich,ANP, CWS, MPH , More opens in new window

H
Harper, Howard Date: 07/18/2007
Comment:

As a physician who has used this technology in
the setting of a wound treatment center, the
benefit that it adds to patient care is
enormous. The PRP has been instrumental in
speeding granulation tissue formation in many of More opens in new window

H
Higgins, Joel Organization: Biomet Biologics, Inc.
Date: 07/24/2007
Comment:

There are numerous reports of the benefits of autologous platelet-rich plasma application in chronic wound care. Many reports are not controlled clinical trials; nonetheless, their descriptions of the potential benefits of PRP therapy are More opens in new window

H
Holloway, Allen Title: Director, Burn Outpatient Services
Organization: Maricopa Medical Center
Date: 07/12/2007
Comment:

Having conducted clinical trials as well as having
used Autologous Blood Derived Products, I feel
they are useful both in acute and chronic wounds,
and that they are superior to single cytokine
products. The current literature More opens in new window

K
Kedzierski, Gail Title: Cardiovascular Perfusionist
Date: 07/06/2007
Comment:

I strongly believe that the use of prp in many if
not all medical situations is benificial, I have
attended meetings where prp has been presented in
the use of non-healing diabetic wounds and the
outcomes are outstanding, I More opens in new window

K
Kirsner, Robert Title: Professor and Vice Chairman
Organization: Department of Dermatology University of Miami
Date: 07/25/2007
Comment:

As academic physician and director of a wound care clinic I wish to comment regarding Autologous Blood Derived Products for Chronic Non- Healing Wounds. Based on positive reported results in the literature, reports at meetings, and my own More opens in new window

L
Lind CCP, Mark Title: Certified Clinical Perfusionist
Organization: Autologous Concepts
Date: 06/29/2007
Comment:

I am a Certified Clinical Perfusionist that has been using PRP 1998. I have used it in many different kinds of procedures, but the most striking benefits are seen in the wound care cases. I have done aprox. 10 cases that were of the severe More opens in new window

M
Melin MD Vascular Surgery, Director Wound Clinic, Matthew Title: MD
Organization: Park Nicollet
Date: 07/23/2007
Comment:

CMS Represerntitive;

I am a vascular surgeon and the Medical Director of a large hospital based outpatient wound care program. As a component of the comprehensive evaluation and management at our wound care program, we used to use AutoloGel More opens in new window

M
Miller, L Title: RN, CWCN
Organization: Pacific Wound Center
Date: 07/20/2007
Comment:

Having trialed the product in our clinic, we did
see a reduction on wound pain and increase in
wound bed granulation. As a free standing clinic
the possiblilies to actually implement platelet-
gel is difficult at this point. We More opens in new window

M
Morgan, Marc Title: Certified Clinical Cardiovascular Perfusionist
Organization: Carolina Perfusion Assoc., Inc.
Date: 07/20/2007
Comment:

I am a cardiovascular perfusionist and have had several years experience with Autologous Platelet Gel Therapy use in the wound center of our hospital as well as surrounding physicians' offices. Last year alone I treated over 60 patients for non- More opens in new window

Page 1 of 2
FirstPrev12NextLast
85